KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
11.31
-0.11 (-0.92%)
At close: Jun 30, 2025, 4:00 PM
11.50
+0.20 (1.72%)
After-hours: Jun 30, 2025, 4:23 PM EDT
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of $562.04 million as of June 30, 2025. Its market cap has increased by 9.37% in one year.
Market Cap
562.04M
Enterprise Value
310.64M
1-Year Change
9.37%
Ranking
Category
Stock Price
$11.31
Market Cap Chart
Since April 9, 2015, KalVista Pharmaceuticals's market cap has increased from $129.30M to $562.04M, an increase of 334.68%. That is a compound annual growth rate of 15.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 567.30M | 35.52% |
| Dec 31, 2024 | 418.60M | -1.11% |
| Dec 29, 2023 | 423.30M | 154.39% |
| Dec 30, 2022 | 166.40M | -48.59% |
| Dec 31, 2021 | 323.70M | -4.99% |
| Dec 31, 2020 | 340.70M | 7.27% |
| Dec 31, 2019 | 317.60M | -6.64% |
| Dec 31, 2018 | 340.20M | 223.69% |
| Dec 29, 2017 | 105.10M | 690.23% |
| Dec 30, 2016 | 13.30M | -86.04% |
| Dec 31, 2015 | 95.30M | -26.30% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |